Structure-based design, discovery and development of checkpoint kinase inhibitors as potential anticancer therapies

Author： Matthews Thomas P   Jones Alan M   Collins Ian  

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.6, 2013-10, pp. : 621-640

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ligand and Structure-Based Pharmacophore Modeling for the Discovery of Potential Human HNMT Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 9, Iss. 1, 2012-01 ,pp. : 17-29

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-Based Discovery of PDEs Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 9, 2016-04 ,pp. : 917-933

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Drugs Design Studies on Spleen Tyrosine Kinase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 9, 2016-11 ,pp. : 845-858

Bentham Science Publishers

Access to resources Recommend Favorite

Successful Structure-Based Design of Recent p38 MAP Kinase Inhibitors

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 7, 2009-05 ,pp. : 655-676

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Cathepsin Inhibitors and Structure-Based Design of Cathepsin B-Specific Inhibitor

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 7, 2010-05 ,pp. : 696-707

Bentham Science Publishers

Access to resources Recommend Favorite